September 18, 2025

Get In Touch

Health Authorities Crack Down on OTC Sale of Antibiotics, NRx Drugs in Visakhapatnam

Visakhapatnam: Health authorities have issued stern warnings to chemists in the city against dispensing NRx drugs and antibiotics without valid prescriptions, a practice that is illegal and contributing to antimicrobial resistance. According to a recent report in The Hindu, regulators stressed that Schedule H, H1, and other prescription-only categories must not be sold over the counter. Chemists found violating these rules are liable to action under the Drugs and Cosmetics Act. The Hindureports that misuse of antibiotics is common in Visakhapatnam, with customers often requesting them directly from pharmacies without visiting a doctor. Officials have urged strict enforcement of rules and called upon pharmacy owners to maintain prescription records, refuse sales without prescriptions, and cooperate during inspections. Enforcement agencies noted that failure to comply not only breaks regulatory norms but also poses serious public health risks in view of rising drug-resistant infections.

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!